Grace Therapeutics annual gross margin
2021
Grace Therapeutics's gross margin was 61.22% for fiscal 2021.
View full Grace Therapeutics company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2021 | 2021-03-31 | 61.22% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2021 | 2020-12-31 | 55.56% | — |
The latest reported quarter, Q3 2021, shows 55.56%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Grace Therapeutics source filings ↗